CORCEPT THERAPEUTICS INC Quarterly Amortization of Intangible Assets in USD from Q1 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Corcept Therapeutics Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2023 to Q1 2024.
  • Corcept Therapeutics Inc Amortization of Intangible Assets for the quarter ending March 31, 2024 was $52K, a 56.3% decline year-over-year.
  • Corcept Therapeutics Inc annual Amortization of Intangible Assets for 2023 was $465K, a 2.52% decline from 2022.
  • Corcept Therapeutics Inc annual Amortization of Intangible Assets for 2022 was $477K, a 16.6% increase from 2021.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $52K -$67K -56.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q1 2023 $119K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.